Literature DB >> 18427549

Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.

L A Frederick1, J A Matthews, L Jamieson, V Justilien, E A Thompson, D C Radisky, A P Fields.   

Abstract

Protein kinase Ciota (PKCiota) drives transformed growth of non-small cell lung cancer (NSCLC) cells through the Rho family GTPase Rac1. We show here that PKCiota activates Rac1 in NSCLC cells by formation of a PKCiota-Par6alpha complex that drives anchorage-independent growth and invasion through activation of matrix metalloproteinase-10 (MMP-10) expression. RNAi-mediated knockdown of PKCiota, Par6alpha or Rac1 expression inhibits NSCLC transformation and MMP-10 expression in vitro. Expression of wild-type Par6alpha in Par6alpha-deficient cells restores transformation and MMP-10 expression, whereas expression of Par6alpha mutants that either cannot bind PKCiota (Par6alpha-K19A) or couple to Rac1 (Par6alpha-DeltaCRIB) do not. Knockdown of MMP-10 expression blocks anchorage-independent growth and invasion of NSCLC cells and addition of catalytically active MMP-10 to PKCiota- or Par6alpha-deficient cells restores anchorage-independent growth and invasion. Dominant-negative PKCiota inhibits tumorigenicity and MMP-10 expression in subcutaneous NSCLC tumors. MMP-10 and PKCiota are coordinately overexpressed in primary NSCLC tumors, and tumor MMP-10 expression predicts poor survival in NSCLC patients. Our data define a PKCiota-Par6alpha-Rac1 signaling axis that drives anchorage-independent growth and invasion of NSCLC cells through induction of MMP-10 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427549      PMCID: PMC2750877          DOI: 10.1038/onc.2008.119

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.

Authors:  Roderick P Regala; Capella Weems; Lee Jamieson; John A Copland; E Aubrey Thompson; Alan P Fields
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

2.  Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.

Authors:  Roderick P Regala; Capella Weems; Lee Jamieson; Andras Khoor; Eric S Edell; Christine M Lohse; Alan P Fields
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.

Authors:  Jason H Gill; Ian G Kirwan; Jill M Seargent; Sandie W Martin; Sidiq Tijani; Vladimir A Anikin; Alan J Mearns; Michael C Bibby; Alan Anthoney; Paul M Loadman
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.

Authors:  L Kren; V N Goncharuk; Z Krenová; D Stratil; M Hermanová; J Skricková; C E Sheehan; J S Ross
Journal:  Cesk Patol       Date:  2006-01

5.  A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.

Authors:  Melody Stallings-Mann; Lee Jamieson; Roderick P Regala; Capella Weems; Nicole R Murray; Alan P Fields
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 6.  Matrigel: basement membrane matrix with biological activity.

Authors:  Hynda K Kleinman; George R Martin
Journal:  Semin Cancer Biol       Date:  2005-10       Impact factor: 15.707

7.  Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.

Authors:  Eda Erdogan; Trond Lamark; Melody Stallings-Mann; Maurizio Pellecchia; Mauricio Pellechia; E Aubrey Thompson; Terje Johansen; Alan P Fields
Journal:  J Biol Chem       Date:  2006-07-22       Impact factor: 5.157

Review 8.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

9.  Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo.

Authors:  Céline Van Themsche; Tommy Alain; Anna E Kossakowska; Stefan Urbanski; Edouard F Potworowski; Yves St-Pierre
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

10.  Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway.

Authors:  Jie Zhang; Panos Z Anastasiadis; Yan Liu; E Aubrey Thompson; Alan P Fields
Journal:  J Biol Chem       Date:  2004-03-22       Impact factor: 5.157

View more
  55 in total

1.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.

Authors:  Michele L Scotti; William R Bamlet; Thomas C Smyrk; Alan P Fields; Nicole R Murray
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.

Authors:  Verline Justilien; Lee Jameison; Channing J Der; Kent L Rossman; Alan P Fields
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

4.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

5.  PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.

Authors:  Yin Wang; Kristen S Hill; Alan P Fields
Journal:  Mol Cancer Res       Date:  2013-10-30       Impact factor: 5.852

6.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

Authors:  Verline Justilien; Michael P Walsh; Syed A Ali; E Aubrey Thompson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

Review 7.  Atypical protein kinase C in cell motility.

Authors:  Helan Xiao; Mingyao Liu
Journal:  Cell Mol Life Sci       Date:  2012-10-25       Impact factor: 9.261

8.  Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.

Authors:  Ning Yin; Yi Liu; Andras Khoor; Xue Wang; E Aubrey Thompson; Michael Leitges; Verline Justilien; Capella Weems; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2019-08-01       Impact factor: 31.743

9.  Protein kinase C betaII and PKCiota/lambda: collaborating partners in colon cancer promotion and progression.

Authors:  Nicole R Murray; Justin Weems; Ursula Braun; Michael Leitges; Alan P Fields
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition.

Authors:  Adrian Gunaratne; Boun L Thai; Gianni M Di Guglielmo
Journal:  Mol Cell Biol       Date:  2012-12-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.